Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

13,800

Employees13,800

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

13,800

Employees13,800

ZTS Key Statistics

Market cap

68.57B

Market cap68.57B

Price-Earnings ratio

26.73

Price-Earnings ratio26.73

Dividend yield

1.24%

Dividend yield1.24%

Average volume

2.55M

Average volume2.55M

High today

$155.26

High today$155.26

Low today

$153.29

Low today$153.29

Open price

$155.26

Open price$155.26

Volume

1.79M

Volume1.79M

52 Week high

$200.33

52 Week high$200.33

52 Week low

$139.70

52 Week low$139.70

ZTS News

TipRanks 1d

Zoetis Secures New $1.25 Billion Credit Facility

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 5d

Zoetis Valuation in Focus After $1.85 Billion Fixed-Income Raise and Balance Sheet Moves

Zoetis (NYSE:ZTS) is back in the spotlight after raising almost $1.85 billion in fresh capital through two new fixed-income offerings, with several global banks...

Simply Wall St 5d

How Investors May Respond To Zoetis Broadening Its Underwriter Base With $1.85 Billion Debt Offerings

Earlier this month, Zoetis completed two major fixed-income offerings totaling approximately US$1.85 billion, issuing callable senior unsecured notes maturing i...

Analyst ratings

76%

of 21 ratings

Buy

76.2%

Hold

23.8%

Sell

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.